Hybrid Tissue Scaffold with Nested Pores for Mechanical Strength
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Engineered tissue implants face challenges in achieving sufficient mechanical strength due to the lack of strength in biomaterial scaffolds, which are often cytotoxic when crosslinked or costly when copolymerized with synthetic polymers, and result in synthetic scaffolds that cells cannot remodel.
Innovation Solution
A hybrid tissue scaffold comprising a primary three-dimensional scaffold with a secondary scaffold within its pores, where the primary scaffold is made from biodegradable polymers like polycaprolactone and the secondary scaffold is formed from natural biomaterials like collagen or chitosan, providing enhanced mechanical strength and a suitable environment for cell proliferation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If biomaterials such as collagen, fibrin, and glycosaminoglycans are used to provide the correct biomaterial environment, then cell compatibility and biomaterial environment are improved, but mechanical strength deteriorates
Solution Approach 1:
The patent combines natural biomaterials (collagen, fibrin, glycosaminoglycans) with synthetic polymers (polycaprolactone, polyglycolic acid, polylactic acid) to create a composite scaffold that exhibits both excellent cell compatibility and enhanced mechanical strength. The composite structure allows the natural biomaterials to provide the biomimetic environment while the synthetic components contribute structural integrity and mechanical properties.
2Strength
If crosslinking is used to increase mechanical strength, then strength is improved, but cytotoxicity increases due to crosslinker residue
Solution Approach 1:
The patent employs alternative crosslinking methods that avoid cytotoxic chemicals, such as enzymatic crosslinking, physical crosslinking, or crosslinking under controlled conditions with thorough rinsing. This changes the crosslinking parameters to eliminate harmful residues while maintaining the enhanced mechanical strength provided by the crosslinked network structure.
3Strength
If copolymerization with stiff synthesized polymer is used to increase strength, then mechanical strength is improved, but manufacturing cost increases and fabrication difficulty increases
Solution Approach 1:
Instead of copolymerization, the patent segments the scaffold into distinct phases: a continuous synthetic polymer matrix providing mechanical strength and integrity, with dispersed natural biomaterial components providing the biomimetic environment. This segmentation allows independent optimization of each component's properties and simplifies manufacturing processes.
4Strength
If scaffold is made from stiff synthesized polymer with large pore sizes, then mechanical strength is improved, but biomaterial content decreases and cell remodeling capability deteriorates
Solution Approach 1:
The patent applies local quality by creating regions with different properties within the scaffold: the synthetic polymer matrix provides mechanical strength in load-bearing regions, while localized domains of natural biomaterials provide cell-friendly environments for remodeling. This spatial differentiation allows both strong mechanical support and active cell remodeling in appropriate locations.
Data Source
AI summary
A hybrid tissue scaffold is provided which comprises a porous primary scaffold having a plurality of pores and a porous secondary scaffold having a plurality of pores, wherein the secondary scaffold resides in the pores of the primary scaffold to provide a hybrid scaffold. The pores of the porous primary scaffold may have a pore size in a range of 0.50 mm to 5.0 mm, and the pores of the porous secondary scaffold may have a pore size in a range of 50 μm to 600 μm. The primary scaffold may provide 5% to 30% of a volume of the hybrid scaffold.